Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Saniona publishes its year-end report for 2020
Saniona ABMarch 17, 2021 GMT
PRESS RELEASE Revenue was SEK 8.2 M (7.2 M) Operating loss was SEK -159.4 (-93.6 M) Net loss was SEK -73.4 M (-68.8 M) Earnings per share were SEK -1.79 (-2.67) Diluted earnings per share were SEK -1.75 (-2.67)
Q4 2020 (Q4 2019 restated) Revenue was SEK 1.6 M (0.0 M) Operating loss was SEK -68.8 M (-28.2 M) Net loss was SEK -45.6 M (-6.8 M) Earnings per share were SEK -0.73 (-0.24) Diluted earnings per share were SEK -0.73 (-0.24)
Boston
Massachusetts
United-states
Denmark
Copenhagen
Køavn
Stockholm
Sweden
Trista-morrison
University-of-pennsylvania
Boehringer-ingelheim
Drug-administration
December 21, 2020
Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the further expansion of its executive team with the appointments of Denelle Waynick as Chief Legal Officer and Kyle
Haraldsen as Chief Technical Operations Officer. The positions will be based in the U.S. and will support Saniona’s advancement of clinical trials for Tesomet and SAN711 as well as the company’s growing U.S. presence.
“This has been a year of transformation for Saniona, evolving from a company focused on early-stage research to one capable of conducting its own mid-stage clinical trials. As we close out 2020, the hiring of Denelle and Kyle completes Saniona’s executive team in support of our current business,” said Rami Levin, President and CEO of Saniona. “As we look to 2021, our entire organization is focused on initiating Phase 2b clinical trials of Tesomet in HO and PWS, as well as advancing SAN711, the first drug candidate
Boston
Massachusetts
United-states
New-jersey
Newark
Northeastern-university
Denelle-waynick
Kyle-haraldsen
University-of-new-jersey
Howard-university-school-of-law
Schering
Johnson-matthey-pharma-services
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Boston
Massachusetts
United-states
Denmark
Copenhagen
Køavn
Stockholm
Sweden
Trista-morrison
Company-presentations
Rami-levin
Chief-executive-officer
vimarsana © 2020. All Rights Reserved.